Endothelium-derived relaxing factor has been recently identified as nitric oxide. The purpose of this study was to determine if vasodilator drugs that generate nitric oxide inhibit vascular smooth muscle mitogenesis and proliferation in culture. Three chemically dissimilar vasodilators, sodium nitroprusside, S-nitroso-N-acetylpenicillamine and isosorbide dinitrate, dose-dependently inhibited serum-induced thymidine incorporation by rat aortic smooth muscle cells. Moreover, 8-bromo-cGMP mimicked the antimitogenic effect of the nitric oxide-generating drugs. The antimitogenic effect of S-nitroso-N-acetylpenicillamine was inhibited by hemoglobin and potentiated by superoxide dismutase, supporting the view that nitric oxide was the ultimate effector. Sodium nitroprusside and S-nitroso-Nacetylpenicillamine significantly decreased the proliferation of vascular smooth muscle cells. Moreover, the inhibition of mitogenesis and proliferation was shown to be independent of cell damage, as documented by several criteria of cell viability. These results suggest that endogenous nitric oxide may function as a modulator of vascular smooth muscle cell mitogenesis and proliferation, by a cGMP-mediated mechanism.
1. Abbreviations used in this paper: EDRF, endothelium-derived relaxing factor; ISDN, isosorbide dinitrate; NO, nitric oxide; SNAP, S-nitroso-N-acetylpenicillamine; SNP, sodium nitroprusside; VIP, vasoactive intestinal polypeptide.
Tennessee 38163 much as EDRF increases vascular cGMP and cGMP analogues as well as agents that increase cGMP mimic the actions of EDRF (9) (10) (11) (12) . In addition, pharmacologic inhibition of the increase of cGMP induced by EDRF attenuates its vasodilatory effect ( 13) .
Recently, our laboratory has shown that atrial natriuretic hormone decreases serum-stimulated DNA synthesis and proliferation of cultured mesangial cells (14) . These cells share many characteristics with systemic vascular smooth muscle cells, including contractile activity. Atrial natriuretic hormone and NO both have the ability to increase vascular cGMP, and based on this observation, we speculated that NO-generating vasodilators would inhibit the mitogenesis and proliferation of vascular smooth muscle cells. We now report that three such structurally dissimilar drugs, as well as 8-bromo-cGMP, effectively inhibit DNA synthesis and proliferation of rat aortic smooth muscle cells in culture.
Methods
S-Nitroso-N-acetylpenicillamine (SNAP) was synthesized according to the method of Field et al., by reaction of NaNO2 and N-acetylpenicillamine, at low pH (15) . The chemical purity of the product was established by thin-layer chromatography on silica gel-GF (Analtech, Newark, DE) with CHC13:CH3OH:H20 (7:3:0.3/vol/vol/vol) as the solvent system (single spot with Rf -0.6), and by determination of the melting point which was found to be 1490-151 IC, similar to the previously reported value of 1 520C (15). Additionally, SNAP was found to have a nuclear magnetic resonance spectrum consistent with the expected chemical structure (results not shown). Sodium nitroprusside (SNP), isosorbide dinitrate (ISDN), and 8-bromo-cGMP were purchased from Sigma Chemical Co. (St. Louis, MO) .
Rat aortic smooth muscle cells were isolated and cultured, as previously described (16) . For the measurement of thymidine uptake, cells, used between the 4th and 11th subculture, were seeded at a density of -2 X l0-4. cm-2 and cultured for 2-5 d in RPMI 1640 medium supplemented with 20% heat-inactivated fetal bovine serum (Gibco Laboratories, Grand Island, NY), insulin (5 ,.Lg/ml), transferrin (5 tg/ml), and selenous acid (5 ng/ml) (Collaborative Research, Lexington, MA) plus antibiotics. To achieve quiescence, aortic smooth muscle cells were washed, three times, with serum-free medium and cultured for 2 d in the same medium further supplemented with 0.5% albumin. To investigate the effect of various agents on mitogenesis, quiescent cells were cultured for 20 h in medium supplemented with or without 5% serum, containing or lacking experimental agents. Finally, cells were incubated for 2 h in freshly prepared media that were additionally supplemented with I uCi [methyl-3H]thymidine (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) Ci * mmol-'; New England Nuclear, Boston, MA), to measure DNA synthesis by thymidine incorporation. The 
Results
SNP and ISDN are drugs that generate NO spontaneously or by intracellularly catalyzed reactions (9, 1 1). SNAP is a similar experimental drug which spontaneously releases NO in aqueous medium (9) . The actions of these drugs on thymidine incorporation into quiescent cultured aortic smooth muscle cells were therefore evaluated. Serum stimulated thymidine incorporation by 15-20-fold, relative to serum-lacking medium (not shown), whereas all three NO-generating vasodilators dose-dependently inhibited the incorporation of thymidine ( Fig. 1) . SNAP was most potent, followed by SNP and ISDN. At the highest concentrations used, SNAP and SNP almost completely inhibited serum-induced thymidine incorporation.
Inasmuch as the effects of the above mentioned vasodilators are generally thought to be mediated by cGMP as the second messenger, we also tested the effect of 8-bromo-cGMP on serum-induced thymidine incorporation. As shown in Fig.  1, 8 -bromo-cGMP dose-dependently inhibited serum-stimulated thymidine incorporation.
Hemoglobin is well established as antagonist of the actions of EDRF/NO, by trapping and/or oxidation (17, 18) . To further identify the agent inducing antimitogenesis, we compared the dose-response relationship of SNAP-induced antimitogenesis in the presence or absence of hemoglobin. Hemoglobin itself had very little effect on serum-induced mitogenesis, decreasing it by 14.3% (n = 3). However, as indicated in Fig. 2 , the dose-response relationship for SNAP-induced inhibition of mitogenesis was shifted to the right by almost an order of magnitude, indicating antagonism of SNAP's antimitogenic activity by hemoglobin.
A second agent that can alter NO levels in aqueous media is SOD (4, 6, 19 ) and the difference between the two curves was significant at P < 0.001, by analysis of variance.
Standard errors are not shown when their magnitude is less than the width of the symbol. generated in oxygen containing media, have the ability to oxidize NO and therefore to decrease its concentration; SOD inhibits or prevents this effect by catalyzing the degradation of superoxide. SOD alone caused a 5% decrease of serum-stimulated thymidine incorporation but, as shown in Fig. 3 , it caused significant potentiation of the antimitogenic activity of SNAP, particularly at low concentrations of SNAP, further supporting the notion that NO was the ultimate effector of antimitogenesis.
The inhibition of DNA synthesis by NO-generating agents indicated that these agents should also inhibit cell proliferation. We tested the effect of the two most potent vasodilators, SNAP and SNP, on the rate of serum-induced cell proliferation. As shown in Fig. 4 , both SNAP and SNP significantly inhibited the rate of aortic smooth muscle cell proliferation.
A trivial explanation of the antimitogenic-effect of NOgenerating agents is that it is the result of the degradation of serum mitogens by a free radical-mediated mechanism. To rule out this possibility, we preincubated serum-containing culture medium with 1 mM SNAP (highest concentration used in our experiments) for 3 d. The half-life of SNAP in aqueous medium has been determined to be -5 h (9), and we reasoned that after 3 d of preincubation, almost all SNAP would be degraded to products that are thought to include the dimer of N-acetylpenicillamine as well as nitrite and nitrate (9) . Preincubated SNAP'(1 mM) decreased thymidine incorporation by 37.5±2.4% (n = 3), relative to serum-containing medium preincubated without SNAP for 3 d, whereas culture 0 120 
Discussion
Recently, we reported that atriopeptins 28 and 24 inhibit serum-induced thymidine incorporation and proliferation of mesangial cells (14) . Inasmuch as atriopeptins are believed to exert most of their biological effects by raising intracellular cGMP, we intended to test the hypothesis that nitric oxidegenerating agents that are well documented to increase cGMP, would also inhibit DNA synthesis and proliferation of smooth muscle cells. In this study we report that three chemically dissimilar, NO-generating vasodilators effectively inhibit DNA synthesis and proliferation of rat aortic smooth muscle cells. This effect was dose dependent, with the order of potency being SNAP > SNP > ISDN.
The two most potent antimitogens, SNAP and SNP, were tested for their ability to inhibit the proliferation of aortic smooth muscle cells. As expected, both drugs significantly decreased the rate ofserum-induced aortic smooth muscle proliferation, consistent with the finding that they inhibited DNA synthesis.
That the antimitogenic and antiproliferative effects ofNOgenerating agents were likely to be due to the action of NO itself was indicated by the decreased potency of SNAP in the presence of hemoglobin. The ability of hemoglobin to inhibit EDRF activity and to trap NO has been shown previously by several groups of investigators (17, 18) . That the maximal effectiveness of SNAP was not affected by hemoglobin could be attributed to the ability of high concentrations of SNAP to generate sufficient NO to overcome the capacity of hemoglobin to bind and inactivate NO. The identity of NO as the ultimate antimitogenic effector was further supported by the potentiation of SNAP-induced antimitogenesis by SOD, an agent that is thought to increase the chemical stability of NO by decreasing superoxide levels in oxygen-containing media (4, 6, 19) .
The antimitogenic effect of NO-generating agents was unlikely to be due to NO-induced cell damage, based on the finding that 1 mM SNAP did not cause the release of lactate dehydrogenase or decrease cell number after 22 h of incubation. Moreover, the inhibition of cell proliferation induced by 0.1 mM SNAP in long-term experiments was also unlikely to be the result of toxicity and damage to cells as shown by the lack of lactate dehydrogenase release into the extracellular medium, the lack of staining by trypan blue and the lack of cell detachment. Concentrations of SNAP higher than 0.1 mM SNAP did however induce a decrease of cell number in longterm experiments, indicating the potential for cell damage by either SNAP or SNAP-degradation products at relatively high concentrations.
Most, if not all, of the antimitogenic effect of NO-generating agents appeared to be the result of a direct interaction with cells rather than degradation of serum mitogens, based on the finding that preincubated SNAP-containing culture medium regained most of its mitogenic activity. The residual inhibition of mitogenesis by degraded SNAP could be due to SNAP degradation products that include nitrite and nitrate, the former of which is a potential NO precursor and could conceivably generate additional NO, by sulthydryl-catalyzed reactions (9) . It is also possible that the dimer of N-acetylpenicillamine, thought to be generated as a result ofSNAP degradation, could inhibit mitogenesis. Still another possibility is that NO, particularly at higher concentrations, did cause some degradation of serum mitogens.
The ability of 8-bromo-cGMP to mimic the antimitogenic effect of NO-generating vasodilators provided preliminary evidence in support of the notion that at least a portion of this effect was likely to be mediated by cGMP as the second messenger. Moreover, this finding also provided further support for the notion that most of the antimitogenic effect was not due to cell toxicity or to degradation of serum mitogens by free radical mechanisms since 8-bromo-cGMP would not be expected to generate free radicals.
Excessive vascular smooth muscle proliferation is considered to be a hallmark ofatherosclerotic disease (20) (21) (22) and the experimental removal of endothelium has been associated with proliferation of the underlying vascular smooth muscle cells (23) (24) (25) . It has therefore been postulated that one of the functions of endothelial cells is to maintain the mitogenic qui-escence ofthe underlying medial vascular smooth muscle cells. Recent studies have also demonstrated the tonic generation of NO and EDRF by endothelial cells (8, 26) . These results, taken together with our present observations, support the possibility that endogenous NO may play an important role as modulator of smooth muscle cell growth and that the lack of endogenous NO might induce excessive proliferation of these cells, consequent to the removal of a tonic inhibitory influence.
